Posted by Michael Wonder on 26 Sep 2017
'Miracle drug' Keytruda should be funded, patients say
26 September 2017 - A 44-year-old father of four given six to nine months to live when he was diagnosed with lung cancer has seen his tumour halve in size thanks to a new treatment he describes as a "miracle drug".
Patients and advocates are calling on Keytruda to be publicly funded for lung cancer, the country's biggest form of cancer death which claims five lives a day, because many patients could not afford the tens of thousands of dollars required to pay for it.
The Cancer Society said the drug, which the UK, Europe and the US funded as a lung cancer treatment, was a "game changer" which would definitely save lives.
